Session Highlights Ethical Practices in NCD Management

Published on: April 28, 2025

A specialized session on The Importance of Ethical Medical Practices in Managing Non-Communicable Diseases (NCDs) was held on April 28, 2025, focusing on the vital role of ethics in the care of patients with chronic conditions such as diabetes, cardiovascular disease, and cancer. With the growing global burden of NCDs, the session emphasized that long-term, patient-centered care must be grounded in ethical principles to ensure compassionate, effective, and equitable health outcomes.

The session underscored key ethical values such as informed consent, patient autonomy, confidentiality, and fairness in access to care. These principles are foundational for building trust between healthcare providers and patients, fostering better treatment adherence, and ensuring dignity in care. It also highlighted how transparency and respectful communication contribute to improved decision-making and satisfaction in long-term care management. The session addressed both clinical and policy-level implications, encouraging future professionals to embed ethics into everyday healthcare practice.

Attended by 63 students from the M.Sc. Yoga Sciences and B.Sc. Yoga Science and Holistic Health programs, the session engaged participants in thought-provoking discussions and real-world case reflections. Students gained a deeper understanding of the ethical challenges and responsibilities involved in managing chronic diseases, particularly in diverse and underserved populations. They were encouraged to consider the human aspect of healthcare, recognizing how ethical practice not only improves individual outcomes but also contributes to reducing broader health disparities.

Overall, the session served as an important platform for fostering ethical awareness among aspiring healthcare professionals. It reinforced the message that clinical competence must be accompanied by ethical integrity to create a truly patient-centered healthcare system. By cultivating respect, empathy, and fairness in medical practice, the session contributed to shaping future practitioners who are equipped to deliver holistic and morally responsible care in the face of rising non-communicable diseases.

Picture2
Picture1
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.